REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial

201530 citationsJournal Articlegold Open Access

Authors

Andrew King · NIHR Birmingham Liver Biomedical Research Unit

Darren Barton · Cancer Research UK Clinical Trials Unit

Heather Beard · NHS Blood and Transplant

Nwe Ni Than · NIHR Birmingham Liver Biomedical Research Unit

Joanna Moore · University of Edinburgh

Christopher Corbett · University of Birmingham

James A. Thomas

Abstract

The trial is registered at Current Controlled Trials on 18 November 2009 (ISRCTN number 91288089, EuDRACT number 2009-010335-41). The findings of this trial will be disseminated to patients and through peer-reviewed publications and international presentations.

Topics & Keywords

Liver Disease and Transplantation Liver physiology and pathology Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ Open

Volume 5, Issue 3, pp. e007700-e007700

DOI: 10.1136/bmjopen-2015-007700

Field-Weighted Citation Impact: 3.35

Command Palette

Authors

Abstract

Topics & Keywords

UN Sustainable Development Goals

Publication Details